• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Double bifurcation optimization stent system technique for left main stenosis.

作者信息

Vassilev D, Mateev H, Alexandrov A, Karamfiloff K, Gil R J

机构信息

National Heart Hospital, Sofia, Bulgaria.

出版信息

J Interv Cardiol. 2014 Dec;27(6):570-3. doi: 10.1111/joic.12155. Epub 2014 Sep 16.

DOI:10.1111/joic.12155
PMID:25224296
Abstract

We present a first-in-man case with implantation in culottes' fashion of two dedicated coronary bifurcation stents (BiOSS Lim) in distal left main stenosis. The immediate procedural and very short-term result was excellent.

摘要

相似文献

1
Double bifurcation optimization stent system technique for left main stenosis.
J Interv Cardiol. 2014 Dec;27(6):570-3. doi: 10.1111/joic.12155. Epub 2014 Sep 16.
2
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局：DELTA 注册研究（左主干冠状动脉疾病药物洗脱支架）：一项多中心注册研究，评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
3
First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.紫杉醇洗脱支架 BiOSS（分叉优化支架系统）治疗冠状动脉分叉病变的首例人体研究：三个月结果。
Kardiol Pol. 2012;70(1):45-52.
4
Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.药物洗脱支架置入治疗无保护左主干冠状动脉疾病后，冠状动脉解剖结构和支架技术对长期预后的影响。
JACC Cardiovasc Interv. 2014 Jan;7(1):29-36. doi: 10.1016/j.jcin.2013.08.013. Epub 2013 Dec 11.
5
Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry).左主干冠状动脉支架植入后的长期预后（来自多中心评估左主干冠状动脉支架置入术最佳经皮冠状动脉介入治疗注册研究）
Am J Cardiol. 2017 Feb 1;119(3):355-364. doi: 10.1016/j.amjcard.2016.10.033. Epub 2016 Oct 31.
6
First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.专用分叉西罗莫司洗脱支架的首次人体研究：BiOSS LIM® 注册研究的 12 个月结果。
J Interv Cardiol. 2015 Feb;28(1):51-60. doi: 10.1111/joic.12180.
7
Immediate and long-term results of a modified simultaneous kissing stenting for percutaneous coronary intervention of coronary artery bifurcation lesions.改良同步亲吻支架置入术用于冠状动脉分叉病变经皮冠状动脉介入治疗的即刻及长期结果
J Invasive Cardiol. 2013 Mar;25(3):126-31.
8
Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.专用分叉紫杉醇洗脱支架BiOSS Expert®治疗左主干远端狭窄
J Interv Cardiol. 2014 Jun;27(3):242-51. doi: 10.1111/joic.12119. Epub 2014 Apr 7.
9
12-month intravascular ultrasound observations from BiOSS® first-in-man studies.来自BiOSS®人体首次研究的12个月血管内超声观察结果。
Int J Cardiovasc Imaging. 2016 Sep;32(9):1339-1347. doi: 10.1007/s10554-016-0926-9. Epub 2016 Jun 17.
10
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial.普通药物洗脱支架与专用冠状动脉分叉西罗莫司洗脱BiOSS LIM®支架对比：随机、多中心、开放标签、对照的POLBOS II试验
EuroIntervention. 2016 Dec 10;12(11):e1404-e1412. doi: 10.4244/EIJY15M11_11.

引用本文的文献

1
BiOSS® Clinical Programme - State of the Art - BiOSS LIM® Stent - The Novel Option for Coronary Bifurcation Treatment.BiOSS®临床项目——最新技术——BiOSS LIM®支架——冠状动脉分叉病变治疗的新选择。
Interv Cardiol. 2015 May;10(Suppl 1):3-6. doi: 10.15420/icr.2015.10.2.S1.